Weitere Artikel dieser Ausgabe durch Wischen aufrufen
To compare the efficacy of desmopressin and placebo in independent geriatric outpatients with nocturnal polyuria (NP).
A prospective, randomized, single-center, national, double blind, placebo-controlled, fixed-dose, parallel group comparative trial was carried out. The study included 110 geriatric outpatients, 55 patients per treatment group using desmopressin acetate nasal spray (strength: 0.1 mg/ml) once daily of 10 μg/spray blast or placebo.
The NP positive geriatric outpatients with >33% nocturnal urine output volume, antidiuretic hormone (ADH) positive or negative were treated over 10 days with intranasal spray in the evening time (7 p.m.), drug or placebo. On day 1 voiding frequency, voiding volumes day and night, serum osmolarity and arginine-vasopressin (AVP) were measured at 7 p.m. On days 2, 5 and 10 creatinine, blood urea nitrogen (bun), blood count and C‑reactive protein (CrP), vena cava diameter and bioimpedance were measured and a structured interview was implemented (voiding frequency, sleeping behavior and subjective and cognitive behavior).
The NP patients showed a mean night voiding volume of 50.60%, 39.21% (n = 102) showed a low AVP level at baseline with no correlation to sodium concentration or voiding frequencies. The primary efficacy criterion, a decrease of the nocturnal voiding frequency during the course of the clinical trial as change from baseline at day 10 (visit 4) was 50% versus 41.40% in the verum versus placebo group, respectively but the differences were not significant. The U‑test showed superiority of AVP-positive NP patients to a positive reaction on desmopressin. Sleeping time hours increased in both groups without significant differences.
In this 10-day clinical trial desmopressin was not proven to be therapeutically superior to placebo with respect to micturition frequency or sleeping hours. Independent geriatric outpatients with decreased ADH levels seemed to respond and benefit from active treatment with desmopressin. The unexpected results in the placebo group may be due to the effect of intensive outpatient care and information on NP outpatients with normal AVP levels.
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten
Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:
Sommer P, Nielsen KK, Bauer T (1990) Voiding patterns in men evaluated by a questionaire survey. Br J Urol 65:155–160 CrossRef
Sommer P, Nielsen KK, Bauer T (1990) Voiding patterns in women evaluated by a questionaire survey. Br J Urol 66:12–15 CrossRef
Van Kerrebroeck P, Abrams P, Chaikin D (2002) The standardisation of terminology in nocturia: report from the standardization sub-committee of the International Continence Society. Neurourol Urodyn 21:179–183 CrossRef
Bliwise DL, Foley DJ, Vitiello MV, Ansari FP, Ancoli-Israel S, Walsh JK (2008) Nocturia and disturbed sleep in the elderly. Sleep Med 10:540–548 CrossRef
Temml C, Ponholzer A, Gutjahr G, Berger I, Marszalek M, Madersbacher S (2009) Nocturia is an age-independent risk factor for hip-fractures in men. Neurourol Urodyn 28(8):949–952 CrossRef
Booth J, McMillan L (2009) The impact of nocturia on older people—implications for nursing practice. Br J Nursing 18(10):592–596 CrossRef
Vaughan CP, Brown CJ, Goode PS, Burgio KL, Allman RM, Johnson TM 2nd (2010) The association of nocturia with incident falls in an elderly community-dwelling cohort. Int J Clin Pract 64(5):577–583 CrossRef
Parsons JK, Mougey J, Lambert L, Wilt TJ, Fink HA, Garzotto M, Barrett-Connor E, Marshall LM (2009) Lower urinary tract symptoms increase the risk of falls in older men. BJU Int 104(1):63–68 CrossRef
Scandi Primus G, Madersbacher H, Elnekheli M, Hanzal E, Heidler H, Böhmer F, Mahn W, Struhal G, Klingler C (2006) Differentialdiagnose und Therapie der Nykturie – Konsensusstatement. J Urol Urogynäkol 13(1):21–27
Füsgen I, Weinrebe W (2000) Nocturnal polyuria syndrome. Eur J Geriatr 2(1):30–34
Kujubu DA, Aboseif SR (2008) An overview of nocturia and the syndrome of nocturnal polyuria in the elderly. Nat Clin Pract Nephrol 4(8):426–435 CrossRef
Asplund R (1999) Mortality in the elderly in the relation to nocturnal micturition. BJU Int 84:297–301 CrossRef
Irwin DF, Abrams P, Milsom I, Kopp Z, Reilly K (2008) Understanding the elements of overactive bladder: questions raised by the EPIC study. BJU Int 101:1381–1387 CrossRef
Hernandez FC, Ristol PJ, Estivil E, Miranda Batista JE, Lopez Aramburu MA (2007) Importance of nocturia and its impact on quality of life in patient with benign prostratic hyperplasia. Actas Urol Esp 31:2623–2629
Yoshimura K, Obara H, Ichioka K (2003) Nocturia and benign prostatic hyperplasia. Urology 61:786–790 CrossRef
Asplund R (2005) Nocturia in relation to sleep, health, and medical treatment in the elderly. BJU Int 96(Suppl 1):15–21 CrossRef
Asplund R (2004) Nocturia, nocturnal polyuria, and sleep quality in the elderly. J Psychosom Res 56(5):517–525 CrossRef
Boongird S, Shah N, Nolin TD, Unruh ML (2010) Nocturia and aging: diagnosis and treatment. Adv Chronic Kidney Dis 17(4):e27–e40 CrossRef
Moon DG, Jin MH, Lee JG, Kim JJ, Kim MG, Cha DR (2004) Antidiuretic hormone in elderly male patients with severe nocturia: a circadian study. BJU Int 94(4):571–575 CrossRef
Mattiason A, Abrams P, Van Kerrebroeck P, Walter S (2002) Efficacy of desmopressin in the treatment of nocturia, a double-blind placebo controlled study in men. BJU Int 89:855–862 CrossRef
Asplund R (2008) Nocturia in relation to sleep, health, and medical treatment in the elderly. BJU Int 95(Supplement 1):15–21
Van Kerrebroeck P, Hashim H, Holm-Larsen T, Robinson D, Stanley N (2010) Thinking beyond the bladder: antidiuretic treatment of nocturia. Int J Clin Pract 64(6):807–816 CrossRef
Van Kerrebroeck P, Rezapour M, Cortesse A, Thüroff J, Riis A, Nørgaard JP (2007) Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study. Eur Urol 52(1):221–229 CrossRef
Asplund R, Sundberg B, Bengtsson P (1999) Oral desmopressin for nocturnal polyuria in elderly subjects: a double-blind, placebo-controlled randomized exploratory study. BJU Int 83(6):591–595 (Apr) CrossRef
- Do independent geriatric outpatients with nocturnal polyuria profit from desmopressin?
Dr. W. Weinrebe
- Springer Medizin